Theralase Technologies Inc. (TLTFF)
OTCMKTS · Delayed Price · Currency is USD
0.1489
-0.0160 (-9.70%)
Aug 29, 2025, 2:56 PM EDT
Theralase Technologies Market Cap
Theralase Technologies has a market cap or net worth of $39.29 million as of August 29, 2025. Its market cap has increased by 13.93% in one year.
Market Cap
39.29M
Enterprise Value
39.44M
Revenue
783.04K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.15
Market Cap Chart
Since April 2, 1996, Theralase Technologies's market cap has increased from 6.14M to 39.29M, an increase of 539.78%. That is a compound annual growth rate of 6.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 39.29M | -13.90% |
| Dec 31, 2024 | 45.64M | 50.64% |
| Dec 28, 2023 | 30.29M | -40.82% |
| Dec 30, 2022 | 51.19M | -15.43% |
| Dec 31, 2021 | 60.53M | 98.73% |
| Dec 31, 2020 | 30.46M | -43.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 832.17M |
| Elite Pharmaceuticals | 734.61M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 655.63M |
| Northwest Biotherapeutics | 448.50M |
| CytoDyn | 376.00M |
| American Oncology Network | 343.87M |